Form D · Biotechnology
SQZ Biotechnologies Co
Watertown, MA · CIK 0001604477
Offering snapshot reported Jun 1, 2020 · SEC filing
- Reported sold
- $66.3M Offering amount: $70.2M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 19, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 1, 2020 | Initial | $66,253,006 | No comparison | 27 | SEC filing |
| Nov 25, 2019 | Initial | $71,253,215 | No comparison | 48 | SEC filing |
| Dec 1, 2016 | Amendment | $24,061,840 | $8,321,927vs Oct 4, 2016 | 34 | SEC filing |
| Oct 4, 2016 | Initial | $15,739,913 | No comparison | 26 | SEC filing |
| Jul 28, 2015 | Amendment | $5,081,019 | $70,000vs Jun 30, 2015 | 24 | SEC filing |
| Jun 30, 2015 | Initial | $5,011,019 | No comparison | 22 | SEC filing |
| Apr 3, 2014 | Initial | $15,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-368023
Source: Form D, filed Jun 1, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Zafrira Avnur | Director |
| Alex Balcom | Executive |
| Alexandra Balcom | Executive |
| Howard Bernstein | Executive |
| Howard Bernstein, M.D., Ph.D. | Executive |
| Marc Elia | Director |
| Kris Elverum | Executive |
| David First | Executive |
| Jonathan Fleming | Director |
| Pushkal Garg | Director |
| Klavs Jensen | Director, Executive |
| Klavs F. Jensen, Ph.D. | Director |
| Lawrence Knopf | Executive |
| Robert Langer | Director |
| Robert Langer, Ph.D. | Director |
| Robert Langer, Sc.D. | Director |
| Agustin Lopez Marquez | Executive |
| Teri Loxam | Executive |
| Eric Moessinger | Director |
| Mark Murcko, Ph.D. | Director |
| Garry A. Nicholson | Director |
| Oliver Rosen, M.D. | Executive |
| Amy W. Schulman | Director |
| Armon Sharei | Director, Executive |
| Armon Sharei, Ph.D. | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
200 Arsenal Yards Blvd., Ste. 210
Watertown, MA, 02472
Watertown, MA, 02472